The Food and Drug Administration has approved FluMist, a nasal spray influenza vaccine that can be self-administered at home. The treatment will be available through a new online pharmacy next year and requires a prescription.
The Food and Drug Administration has approved a nasally-administered influenza immunization treatment that can be taken at home. FluMist — a nasal spray vaccine that AstraZeneca initially developed as an in-office treatment two decades ago — will still require a prescription to obtain and is expected to be made available via a new online pharmacy next year, according to The New York Times. The treatment will require people to fill out a questionnaire on the upcoming FlueMist Home website.
It has been available through healthcare providers ever since it was first approved by the FDA back in 2003. It’s suitable for people aged between 2 to 49 years old — though the FDA recommends that the nasal spray be administered by a parent/caregiver to anyone under 18. The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or inconvenient to travel for flu immunization treatments.
Fluvaccine Nasallyadministered Athometreatment Fdaapproval Healthcare
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves Nasal Spray Flu Vaccine You Can Give Yourself (or Your Kids) at HomeThe FDA has approved FluMist, a nasal spray flu vaccine, to be self-administered at home. Here's what to know.
Read more »
FDA approves first nasal spray flu vaccine for use at homeConsumers with a prescription will be able to order FluMist online starting next year.
Read more »
Doctor not included: FDA approves first flu vaccine that can be taken at homeThe Food and Drug Administration announced Friday it has approved the first flu vaccine that individuals can give to themselves at home, without the need for a healthcare professional.
Read more »
No needles required: The FDA approves an at-home flu vaccineThe nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the flu.
Read more »
No needles required: The FDA approves an at-home flu vaccineThe nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the flu.
Read more »
FDA approves first at-home syphilis test to combat U.S. rise in sexually transmitted infectionThe at-home syphilis test, which is available without a prescription, gives results in about 15 minutes. Other at-home syphilis tests currently on the market require consumers to send their sample to a lab, the FDA said.
Read more »